SynthesisSeminars in arthritis and rheumatism2025
Identification of idiopathic inflammatory myopathy research cohorts using international classification of disease (ICD) codes: A systematic review.
Synthesis in Seminars in arthritis and rheumatism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo summarize studies validating International Classification of Disease (ICD) coding for idiopathic inflammatory myopathies (IIM) case identification, focusing on dermatomyositis (DM) and polymyositis (PM).
methodsPubMed, Scopus, Embase, and CINAHL search was performed with a medical librarian (Prospero #CRD4202452377). Inclusion criteria required: English language, use of ICD-9 and/or -10 coding to identify cases, and clear method for validating cases.
results3684 citations were screened by title/abstract resulting in 69 full-text publications reviewed with 11 articles meeting inclusion criteria. Of the included studies, 5 evaluated only ICD-9, 5 evaluated only ICD-10, and one study evaluated both. All but one study in the US were single center, while those in Europe (n = 4) and Canada (n = 1) were population based. Reference standards varied, including Bohan and Peter (n = 5), 2017 EULAR/ACR classification (n = 2), expert opinion (n = 3), enrollment in Rheumatology Quality Register (n = 1) and muscle biopsy (n = 1). Four studies had a positive predictive value (PPV) of 0.9 or higher; two of these studies used coding associated with inpatient admission, and another required at least 2 codes (710.3) 3 months apart. Multiple coding instances decreased the sensitivity but increased PPV.
conclusionsICD coding is a valuable tool for identifying cases in bioinformatic research. Only a few studies describe ICD code validation for IIM research cohort construction. The highest PPV's are reported for DM and PM with the use of multiple coding instances, or those instances associated with inpatient admission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.